This indicates high public interest in GLP-1 RAs and highlights priorities for clinical and policy communities, including monitoring side effects, addressing access barriers, and acknowledging both the physical and psychological benefits of these drugs
Were not there yet
Plus, there was a cool air blast that followed the machine to soothe the skin (and my mind)
Cardiometabolic markers (TRIUMPH-1, 80 weeks) This profile reads more like metabolic reprogramming than appetite suppression: Triglycerides: 41.0% Non-HDL cholesterol: 24.2% Systolic blood pressure: 12.3 mmHg Waist circumference: 24.1 cm (9.5 inches) What to Watch For: The Most Common Side Effects Retatrutides safety profile is broadly consistent with the GLP-1 class, with one genuinely new signal
If you want a proven weight loss medication right now, tirzepatide (Zepbound) and semaglutide (Wegovy) are FDA-approved, available by prescription, and produce meaningful results
The flip side is a BBB profile that tells a different story